Invitation to presentation of Orkla’s second quarter 2026 results
Idag, 08:00
Idag, 08:00
Orkla will report its second quarter 2026 results on Thursday, 20 August 2026 at 7:00 a.m. CEST.
The quarterly report and the presentation material will be available at this time at Orkla’s website
The presentation and subsequent Q&A session will be held in English at 08:30 a.m. CEST.
A live webcast will be available at: https://events.streamhub.no/orkla-asa-1/presentations/urr3jcqJV5yaj8hzNnhB
Questions can be asked in writing via the webcast.
Journalists:
President and CEO Nils K. Selte will be available for 1:1 interviews between 09:30–10:00 a.m. CEST. Interview slots must be booked in advance through press contact Joachim Gresslien (+47 90 72 50 18).
Orkla ASA
Oslo, 6 August 2026
Ref.:
SVP Investor Relations and Communication
Annie Bersagel
Phone: +47 98 60 36 64
Email: annie.bersagel@orkla.no
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-06 08:00 CEST.
Idag, 08:00
Orkla will report its second quarter 2026 results on Thursday, 20 August 2026 at 7:00 a.m. CEST.
The quarterly report and the presentation material will be available at this time at Orkla’s website
The presentation and subsequent Q&A session will be held in English at 08:30 a.m. CEST.
A live webcast will be available at: https://events.streamhub.no/orkla-asa-1/presentations/urr3jcqJV5yaj8hzNnhB
Questions can be asked in writing via the webcast.
Journalists:
President and CEO Nils K. Selte will be available for 1:1 interviews between 09:30–10:00 a.m. CEST. Interview slots must be booked in advance through press contact Joachim Gresslien (+47 90 72 50 18).
Orkla ASA
Oslo, 6 August 2026
Ref.:
SVP Investor Relations and Communication
Annie Bersagel
Phone: +47 98 60 36 64
Email: annie.bersagel@orkla.no
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-06 08:00 CEST.
Rapporter
Fonder
Aktieanalys
AstraZeneca
Rapporter
Fonder
Aktieanalys
AstraZeneca
1 DAG %
Senast
OMX Stockholm 30
0,01%
(10:05)
Yubico
Idag, 10:02
Yubico rapportrusar
OMX Stockholm 30
1 DAG %
Senast
3 327,33